Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

mPFC Synaptosome Proteomics Reveals Novel Pathways and Muscarinic Receptor Changes in a Learned Helplessness Mouse Model.

eNeuro·2026
Same author

Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction Using Three Independent Cohorts.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

mPFC Synaptosome Proteomics Reveals Novel Pathways and Muscarinic Receptor Changes in a Learned Helplessness Mouse Model.

bioRxiv : the preprint server for biology·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Ryanodine receptor 2-mediated calcium leak is associated with increased glyoxalase I in the aging brain.

JCI insight·2025
Same author

Myelin-axon interface vulnerability in Alzheimer's disease revealed by subcellular proteomics and imaging of human and mouse brain.

Nature neuroscience·2025

Related Experiment Video

Updated: May 11, 2026

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
11:49

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

Recent advances in quantitative neuroproteomics.

George E Craft1, Anshu Chen, Angus C Nairn

  • 1Division of Molecular Psychiatry, Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, Yale University School of Medicine, New Haven, CT 06508, USA.

Methods (San Diego, Calif.)
|April 30, 2013
PubMed
Summary
This summary is machine-generated.

Quantitative proteomics is advancing rapidly, offering new insights into brain function and disorders. Despite challenges in analyzing specific cell types, recent mass spectrometry-based methods are improving our understanding of neuroproteomics in diseases like Alzheimer's and Parkinson's.

More Related Videos

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Related Experiment Videos

Last Updated: May 11, 2026

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
11:49

Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue

Published on: August 28, 2021

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

Area of Science:

  • Proteomics and Neuroproteomics
  • Advancements in Mass Spectrometry and Bioinformatics

Background:

  • The central nervous system presents unique challenges for quantitative proteomics due to intermixed neuronal cell types with distinct expression patterns.
  • Despite these challenges, quantitative proteomics is increasingly applied to neurobiological investigations.

Purpose of the Study:

  • To review recent advances in quantitative neuroproteomics, focusing on the last five years.
  • To highlight the application of emerging methods to normal brain function and neuropsychiatric/neurodegenerative disorders.

Main Methods:

  • Review of mass spectrometry (MS)-based approaches, including label-based (e.g., SILAC, TMT) and label-free quantification (e.g., MRM, SWATH).
  • Comparison with older methods like two-dimensional polyacrylamide electrophoresis.
  • Application to brain tissue and cerebrospinal fluid (CSF) analysis.

Main Results:

  • Emerging MS-based methods enable in-depth peptide and protein identification, modification analysis, and sensitive quantitation.
  • These methods are being applied to study normal brain function and disorders like schizophrenia, drug addiction, Parkinson's, and Alzheimer's disease.
  • Recent studies show improved quality and depth in quantitative proteomics, shedding light on brain function and disease mechanisms.

Conclusions:

  • Quantitative neuroproteomics is rapidly evolving, providing deeper insights into brain function and disease.
  • Standardization of experimental design and data analysis is needed.
  • Analyzing specific neuronal cell types remains a significant challenge, but progress is being made.